Antisense Therapeutics Limited’s (PER) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Antisense Therapeutics Limited is a Buy.

Antisense Therapeutics Limited’s (PER) 20-Day exponential moving average is 0.08, while Antisense Therapeutics Limited’s (PER) share price is <AU$0.1, making it a Buy.

Antisense Therapeutics Limited’s (PER) 50-Day exponential moving average is 0.08, while Antisense Therapeutics Limited’s (PER) share price is <AU$0.1, making it a Buy.

Antisense Therapeutics Limited (PER) Pivot Points

May 10, 2024, 12:20 PM

Classic

0.08

0.09

Fibonacci

0.08

0.09

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Antisense Therapeutics Limited (PER) Moving Averages

May 10, 2024, 12:20 PM

MA5

0.08Buy

MA10

0.08Buy

MA20

0.09Buy

0.08Buy

MA50

0.08Buy

MA100

0.07Buy

MA200

0.06Buy

0.07Buy

Antisense Therapeutics Limited’s (PER) 10-Day exponential moving average is 0.08, while Antisense Therapeutics Limited’s (PER) share price is <AU$0.1, making it a Buy.

Antisense Therapeutics Limited’s (PER) 100-Day exponential moving average is 0.07, while Antisense Therapeutics Limited’s (PER) share price is <AU$0.1, making it a Buy.

Antisense Therapeutics Limited’s (PER) stock price is <AU$0.1 and Antisense Therapeutics Limited’s (PER) 50-day simple moving average is 0.08, creating a Buy signal.

Antisense Therapeutics Limited’s (PER) stock price is <AU$0.1 and Antisense Therapeutics Limited’s (PER) 100-day simple moving average is 0.07, creating a Buy signal.

Antisense Therapeutics Limited’s (PER) stock price is <AU$0.1 and Antisense Therapeutics Limited’s (PER) 200-day simple moving average is 0.06, creating a Buy signal.

Antisense Therapeutics Limited (PER) Technical Indicators

May 10, 2024, 12:20 PM

RSI (14)

57.47

Neutral

STOCH (9,6)

46.30

Neutral

STOCHRSI (14)

32.19

Neutral

MACD (12,26)

<0.01

Buy

ADX (14)

33.87

Neutral

Williams %R

-44.00

Buy

CCI (14)

-4.64

Neutral

ATR (14)

<0.01

Ultimate Oscillator

37.70

Neutral

ROC

-7.29

Sell

Antisense Therapeutics Limited’s (PER) Relative Strength Index (RSI) is 57.47, creating a Neutral signal.

Antisense Therapeutics Limited’s (PER) Trend Strength Indicator (ADX) is 33.87, creating a Neutral signal.

Antisense Therapeutics Limited’s (PER) Commodity Channel Index (CCI) is -4.64, creating a Neutral signal.

Antisense Therapeutics Limited’s (PER) Price Rate of Change (ROC) is -7.29, creating a Sell signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is PER a Buy, Hold, or Sell?

Based on PER’s technical indicators, PER is a Strong Buy.

What is PER’s RSI (14)?

PER’s RSI (14) is 57.47, which suggests PER is a Neutral.

What is PER’s MACD?

PER’s MACD is <0.01, which suggests PER is a Buy.

What is PER’s 5-day moving average?

PER’s 5-day moving average is 0.08, which suggests PER is a Buy.

What is PER’s 20-day moving average?

PER 20-day moving average is 0.09, which suggests PER is a Buy.

What is PER’s 50-day moving average?

PER’s 50-day moving average is 0.08, which suggests PER is a Buy.

What is PER’s 200-day moving average?

PER’s 200-day moving average is 0.06, which suggests PER is a Buy.

What is PER’s Williams % R (14)?

PER’s Williams % R (14) is -44.00, which suggests PER is a Buy.

What is PER’s CCI (14)?

PER’s CCI (14) is -4.64, which suggests PER is a Neutral.

What is the share price of Antisense Therapeutics Limited?

Antisense Therapeutics Limited's share price is 0.09AU$.

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing